REFILE-CORRECTED-Roche aims for 11 late-stage trials in cancer immunotherapy drug this year

BASEL, April 13 (Reuters) - Roche aims to have an immunotherapy cancer drug in 11 late-stage trials by the end of the year, the Swiss drugmaker's head of medical affairs for oncology, Niko Andre, said at a conference on Monday.